Hot Life Science Investor Mandate 7: Cross-Border VC Looking At Healthcare Technology for Emerging Markets  

26 Nov

A venture capital firm with offices in California and Hong Kong invests across a variety of sectors, including biotech and medical technology, and will be raising a second fund in 2015.  The firm typically invests $500,000-$1 million, and prefers to invest in seed or Series A rounds. The firm makes up to 12 allocations per year, and is interested in opportunities globally; companies developing products that can impact healthcare delivery in emerging markets such as China or India are of particular interest.

Within the life science field, the firm has a wide range of interests that include immuno-oncology, medical devices (particularly those involving sensors or remote technologies), software, wearables and consumer healthcare devices, and instrumentation/equipment for the healthcare or biotech sectors.  For therapeutic companies, Phase II opportunities are preferred but earlier opportunities may be considered; for medical devices, opportunities may be considered from development-stage through commercialization.  The firm does not invest in diagnostics.  The firm’s previous experience in the life science sector includes immuno-oncology drugs and 3D microscope technology.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: